Staburo GmbH was represented by our Managing Director, Roland Stieger, at the Biotechnology Innovation Organization (BIO) International Convention from June 16-19, 2025, in Boston. It was an exceptional opportunity to connect with full-service CROs, biotech and big pharma companies, all of whom share our commitment to advancing the future of healthcare.
Our presence at this event allowed us to showcase Staburo’s expertise in biostatistics, statistical programming, and data management – core areas where we have established a reputation as a trusted strategic partner. The insightful discussions we engaged in, highlighted the value of our tailored solutions, which are designed to support both ongoing and future projects. We were excited to demonstrate how Staburo can streamline complex biostatistics and data management processes, ultimately driving the success of biotech companies in a rapidly evolving market.
The convention also provided an invaluable platform to forge new partnerships and strengthen existing relationships. We are thrilled with the productive conversations that took place and are excited about the collaborations already in the pipeline. At Staburo, we remain committed to continuing these discussions and providing ongoing support to our partners as they advance research and development efforts.
We look forward to seeing the lasting impact of the connections made in Boston!
